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The reprogramming of metabolism has been identified as one of the hallmarks of 
cancer. It is becoming more and more frequent to connect other diseases with metabolic 
reprogramming. This article aims to argue that metabolic reprogramming is not driven 
by disease but instead is the main hallmark of metabolism, based on its dynamic 
behaviour that allows it to continuously adapt to changes in the internal and external 
conditions.
Keywords:  metabolism; metabolic reprogramming; hypoxia; cancer; ultradian 
rhythms; immunometabolism


































































The renewed interest in metabolic aspects of oncology and the accumulation of data 
on the topic since the 1990s led Hanahan and Weinberg to propose "deregulating 
cellular energetics" as one of the "new" emerging hallmarks of cancer in the 2011 
revised version of their classic review on the hallmarks of cancer.[1,2] Currently, this 
deregulation of cellular energetics is commonly termed "metabolic reprogramming" 
and is widely accepted to be a common feature of clinically relevant cancers. In 
contrast, if we focus our attention on what is known regarding metabolism, the 
flexibility or plasticity of metabolism emerges immediately as an intrinsic property of 
metabolism itself, allowing living beings to adapt continuously to ever-changing 
internal and environmental conditions. This simple but underestimated idea will be the 
core concept discussed in the present article. Starting with limitations in the most 
accepted definitions of metabolism, and following with an overview of the ups and 
downs of the interest in the scientific study of metabolism, this article argues in favor of 
the understanding of metabolism as a complex dynamic network. Furthermore, it 
reviews evidence clearly pointing to the fact that metabolic reprogramming of cancer is 
but a consequence of the intrinsic capacity of the metabolic network to rewire itself 
dynamically.
2. The Concept of Metabolism: More than just Intracellular Biochemistry
Classically, metabolism has been understood in the terms in which Hans Kornberg 
still defines it today in the corresponding entry of the Encyclopaedia Britannica 
(electronic version): "the sum of the chemical reactions that take place within each cell 
of a living organism and that provide energy for vital processes and for synthesizing 

































































new organic material".[3] Explicitly, this definition excludes such fundamental physical 
processes as the absorption of light in photosynthesis and all processes (yes, metabolic 
ones) that occur across the plasma membrane, on the cell surface or in extracellular 
spaces. Moreover, it is disturbing, to say the least, that the author discriminates against 
biosynthetic processes as if they did not belong to a larger group of "vital processes". 
The Spanish version of Wikipedia defines metabolism as: "the set of biochemical 
reactions and physicochemical processes that occur in a cell and in the organism".[4] 
This definition seems more accurate than the one provided by the English version of 
Wikipedia, which still restricts its definition to chemical transformations occurring 
exclusively within cells: "Metabolism (from Greek: μεταβολή metabolē, "change") is 
the set of life-sustaining chemical transformations within the cells of organisms".[5] My 
experience of decades of teaching metabolism allowed me to introduce a more complete 
and integrative definition of metabolism in the late 1980s, long before this approach 
started to make inroads into biochemistry textbooks and then into the largest of the 
generic encyclopedias, Wikipedia. The definition I propose for the concept of 
"metabolism" is based on the consideration of life as an open thermodynamic system, 
according to which a living being is a thermodynamic system far from equilibrium and 
in continuous exchange of matter, energy and information with its environment. 
Metabolism should be considered the "engine" of life, providing the complex set of 
physicochemical processes that guarantee that adequate exchange of matter, energy and 
information with the environment (see Box 1: Metabolism, the engine of life). However, 
this might not be enough. At the end of this article, I will argue why I am increasingly 
convinced that metabolism is more than the engine of life. 
3. The Metabolic Network: Far from a Still Photo with Simple Dots and Lines

































































Metabolism is now seen as a complex network, as illustrated by the iconic metabolic 
map originally edited by Gerhard Michal and currently maintained in electronic format 
and navigable by the company Roche.[6] The overview map of the global metabolic 
pathways provided by KEGG (Kyoto Encyclopedia of Genes and Genomes) Pathway 
database [7] (Figure 1) is an abstraction of metabolism built as a network in which each 
node represents a metabolite and the edge connecting two nodes represents the 
biochemical reaction allowing the transformation of the first metabolite in the second. 
In this figure the different colors highlight the modularity of metabolism, in which sugar 
lipid, amino acid, nucleotide and energy metabolism modules, among others, are tightly 
interconnected. A much-simplified version of this map is currently used by two of the 
most popular biochemistry textbooks in their respective introductory chapters to 
metabolism, its design and its regulation.[8,9]
Modern network theory has confirmed that the metabolic network is more robust and 
resistant to "targeted attacks" than so-called "scale-free" networks, and that this is due to 
the special topological structure of the metabolic network, which is at once hierarchical 
and modular (Figure 2).[10-13] In fact, Barabasi's group as the first to report that the 
metabolic networks of a number of different organisms are organized into numerous 
highly connected topologic modules and that these modules hierarchically combine into 
larger, although less cohesive, units. Furthermore, the same study revealed that the 
hierarchical and modular topology of E. coli metabolic network reflects the true 
functional organization of metabolism.[10] More recently, it has been found that this 
particular robustness of metabolic networks is the consequence of an evolutionary 
process that acquires and increases functional redundancy based on gene duplication 
and redundant reaction rewiring.[14] Furthermore, in complex biological communities 

































































such as those present in microbiomes, it has recently been shown that metabolic 
network percolation  quantifies how robustly a global metabolic network can produce a 
given set of metabolic products in different environments and during environmental 
change.[15]
Unlike the usual representation of metabolic networks such as those provided by 
KEGG in which there is only one class of nodes (metabolites) and only one class of 
edges (metabolic reactions), Mark Newman suggests that the most natural network 
representation of metabolism and metabolic processes is as bipartite networks. In all 
bipartite networks, there are two different classes of nodes and edges run only between 
nodes of different classes. For the case of bipartite metabolic networks, both classes of 
nodes are metabolites and metabolic reactions. Edges join each metabolite node to the 
reaction nodes in which it takes part.[13]
However, any of the multiple versions of the metabolic map available on the Internet 
represents a "still photo", far removed from an essential peculiarity of the metabolic 
network: its dynamic character, essential to understand the "plasticity" of the 
metabolism to adapt continuously to changes in external and internal conditions.
4. The Ups and Downs of the Interest in the Scientific Study of Metabolism
The 1920s and 30s marked the first "golden age" of metabolism studies, defining and 
characterizing the main pathways thanks to the work of an exceptional generation of 
biochemists including Embden, Meyerhof, Warburg, Krebs, Szent-Györgyi and 
Lipmann, among many others. Major pathways of primary metabolism, such as 
glycolysis, fatty acid beta-oxidation, the urea cycle and the tricarboxylic acid cycle, 
among others, were elucidated in this period. In the fifties and sixties, a second "golden 

































































age" of metabolism ushered in studies on bioenergetics, notable contributors being 
Nobel laureates Calvin and Mitchell, but also Lehninger, Kennedy and Crane, among 
others. Components of the electron transport chain were investigated and described, 
coenzyme Q was discovered, photophosphorylation and the photosynthetic assimilation 
of inorganic carbon to produce new organic matter were described and the chemosmotic 
theory was proposed (and many years after its initial description by Peter Mitchell was 
accepted) as one of the main unifying principles of biology.[16]
However, with the advent of the scientific-technological revolution of recombinant 
DNA in the mid-seventies, the scene changed under a paradigmatically powerful 
"genocentric" approach to Biology, which prevailed until the end of the twentieth 
century. This quarter century was a bit like the "Dark Ages" for metabolic studies, 
which were "discredited" as "old-fashioned" and outside of the mainstream dictated by 
fashion. Everything changed, and the metabolism was again in the spotlight (and so on 
to this day) with the "rediscovery" of the Warburg effect by a new generation of 
scientists interested in metabolism using the most current tools and techniques of 
biochemistry and molecular biology, including "omic" approaches.
5. Metabolic Reprogramming in Cancer: Substrate Shifts and the Modulation 
of Metabolism by the Microenvironment
More than 90 years ago, Otto Warburg observed that a rat carcinoma produced large 
amounts of lactate even in the presence of oxygen, in apparent contradiction with the 
so-called Pasteur effect -the inhibition of glucose consumption in the presence of 
oxygen.[17] Furthermore, Warburg observed that the production of lactate by malignant 
tumours was higher than that by benign, less aggressive ones. The identification of this 

































































aerobic glycolysis (later known as the Warburg effect), a feature common to multiple 
tumour cell types was but the beginning of our current knowledge of the peculiarities of 
tumour metabolism.[18] Almost thirty years after his seminal observation of aerobic 
glycolysis, Warburg also observed that cancer cells obtain similar amounts of energy by 
oxidative phosphorylation and by aerobic glycolysis, in spite of the fact that the ATP 
yield of the first process is 15-16 fold  that of the second process.[18]
In the midst of the "Dark Ages" of metabolic studies, evidence was presented that 
glutamine can supply glucose as the main source of energy in certain types of tumour 
cells, as is the case in HeLa cells.[19] Subsequently, it was demonstrated that elevated 
glutaminolysis is also a characteristic metabolic behaviour of many tumour cells.[20,21] A 
process of investigation into the interrelationships between glucose and glutamine 
metabolism in cancer was started, and finally concluded that the preferential use of 
glucose or glutamine as metabolic subst ate depends on the specific context of a tumour 
cell.[21-25]
As stated above, the "rediscovery" of the Warburg effect at the dawn of the new 
millennium has proved to be a determining factor for the renewed interest in tumour 
metabolism that we witness today.[26-28] For those of us who studied tumour metabolism 
in the 1980s and early 1990s against all odds at the height of the genocentric approach 
to biology, it came as no surprise that the "rediscovery" of the Warburg effect was 
followed by the "rediscovery" of the relevance of glutamine metabolism in tumour 
metabolism.[29-31] It is now fully accepted that in cancer there is a general 
reprogramming of cellular metabolism, and that such metabolic reprogramming is, in 
fact, one of the "hallmarks" of cancer.[1] Indeed, we now know that cancer not only has 
altered metabolism of glucose and glutamine, but also that of other amino acids, fatty 
acids, cholesterol and polyamines.[31-39] In recent years there has been an increasing 

































































number of articles analyzing the reprogramming of metabolism in different types of 
cancer -as well as its potential for targeting- or papers describing the role of specific 
drivers of such a reprogramming.[40-59]
But cancer does not grow in a vacuum, rather in the context of specific host tissues 
and organs. Therefore, it is necessary to reanalyse not only the metabolism of tumour 
cells but also the complex metabolic interrelations between the different cell types 
within the tumour microenvironment and between the tumour and the host organism: a 
clear manifestation of the concept that metabolism is not confined to the interior of a 
single cell.[60,61] Our group was the first to demonstrate 30 years ago that a change in the 
glutamine metabolism of the host organism occurs very early in the development of a 
tumour and that an exchange of amino acids is established between the host and the 
tumour to contribute to the growth of the tumour.[62-64] Lately there has been renewed 
interest in exploring the metabolic interrelationships in the tumour 
microenvironment.[65-73] Recently, our group has contributed with an updated and 
complete review on metabolism in the tumour microenvironment.[74] We have also 
reviewed the connections of redox metabolism reprogramming in the context of tumour 
angiogenesis.[75]
6. Metabolic Reprogramming as a Characteristic Property of the Dynamic 
Character of Metabolism
Authors as prominent as Craig B. Thompson, Mathew Vander Heiden, Ralph 
DeBerardinis, Karen Vousden, Eyal Gottlieb and Almut Schulze lead the legion of 
authors who in the last twenty years have gradually "rediscovered" the importance of 
reprogramming in the metabolism of carbohydrates, lipids and nitrogen metabolites in 

































































cancer, finding welcoming homes for their work in the most important scientific 
journals.[76-85] Not wishing to deny the merit of the good science that all of them are 
carrying out, I insist on using the term "rediscovery" because a good part of these 
findings had already been made (albeit with less sophisticated technical procedures than 
the current ones) decades before, as exemplified by the little known and cited (and yet 
indispensable) book "Biochemical Aspects of Tumour Growth", by V.S. Shapot.[60] The 
increasing number of research groups involved in metabolic studies is a clear evidence 
of the current renewed interest in metabolism. To the list of brilliant scientists involved 
in metabolic studies mentioned above, it is fair to add the important contributions in the 
field published by Peter Carmeliet, whose group in the last decade has been mimetically 
reproducing the steps of metabolic reprogramming in endothelial cells during 
angiogenesis. In this way, and in but a few years, he has gone from remarking that 
glycolytic metabolism is essential for endothelial cells[86] to "discovering" the 
importance of the oxidation of fatty acids and, more recently, of the metabolism of 
amino acids such as glutamine, asparagine or serine in angiogenesis.[87-89] All this has 
contributed to the establishment of the concept of global reprogramming of metabolism 
in the tumour microenvironment.[65,74,90]
However, all these metabolic changes and adaptations that are "sold" as 
"exceptional" and as a distinguishing mark of the cancer itself are no more than the 
reflection of the complex and dynamic character of the metabolic network, and tis 
ability to adapt to the changes and the metabolic and bioenergetics demands of each 
situation.[74,91] According to this concept, metabolic reprogramming of cancer would 
simply represent a (certainly remarkable) example of the flexibility and adaptability of 
metabolism.  In the rest of this section, I will comment on some other relevant examples 

































































of the dynamic potential of metabolism to fine-tuning living beings with changes in 
both internal and external environments.
6.1. Metabolic reprogramming in the transitions between normoxia and hypoxia
We need to go back more than 40 years ago to identify one of the first published 
scientific papers illustrating this concept, when the group then led by Professor Federico 
Mayor Zaragoza demonstrated that the facultative anaerobic organism Saccharomyces 
cerevisiae (baker's yeast) adapted its metabolism in the transition from normoxia to 
hypoxia with a drastic reduction of 2-oxoglutarate dehydrogenase activity: in practical 
terms, the "rupture" of the Krebs cycle and its transformation into the two branches of a 
biosynthetic route (of glutamate and compounds of 4 carbons) that also operates in strict 
anaerobic organisms (see Figure 3).[92] Some years later, these observations were 
confirmed in another facultative anaerobic organism, the prokaryotic cell Escherichia 
coli.[93] Hypoxia induces HIFs (Hypoxia Inducible Factors), transcription factors that in 
turn modify the pattern of expression of many genes coding for proteins involved in 
metabolic processes.[94,95] In fact, not only hypoxia but also circadian and ultradian 
rhythms, immune system responses, exercise, hibernation and practically any other 
environmental or internal factor (including aging) involving a change in the energetic 
and biosynthetic demands of an organism are capable of modulating the gene 
expression and metabolic characteristics of cells, as briefly highlighted with the 
examples that follow.
6.2. Metabolic reprogramming is associated with circadian and ultradian rhythms
 It is well known that the interaction of cell-autonomous circadian clocks with 
fasting/feeding and dark/light cells gives rise to the circadian oscillation of thousands of 

































































genes, thus impacting on their biological function. Many of these genes with circadian 
oscillations are directly or indirectly related to metabolism.[96-99] 
Besides circadian rhythms, plants and animals also exhibit other periodic 
oscillations, such as the half-a-day cell-autonomous clock linked to cycles of light-
darkness and/or with a circatidal origin.[100,101] But even shorter metabolic oscillators 
have been described with periods of the order of minutes in yeasts. The so-called yeast 
metabolic cycle (YMC), with a 40-min period, is particularly well characterized.[102-104] 
It has been proposed that the logic of this YMC is to make possible a temporal 
compartmentalization of cellular processes.[103] However, this is only one of a group of 
metabolic oscillations with periods ranging from 1 min to several hours and collectively 
known as ultradian metabolic cycles.[105,106] These short period metabolic oscillations 
are not a consequence of the cell cycle, and thus they are deemed to be autonomous.[107] 
Although widely studied in the present century, these ultradian metabolic cycles are 
far from being a novelty in science: damped and undamped glycolytic oscillations in 
budding yeast were initially described almost sixty years ago.[108-110] Since these 
pioneering studies, yeast has been the most frequently used model organism for studies 
of metabolic oscillations. However, these oscillations are not the prerogative of 
unicellular organisms, as revealed by Klevecz and Ruddle as early as 1968, when they 
described cyclic changes in enzyme activities in synchronized mammalian cell 
cultures.[111] Many other metabolic oscillations have been described in complex 
multicellular organisms, including plants and animals. For instance, photosynthetic 
oscillations are well documented, being initiated and supported by imbalances in 
NADPH and ATP supply to the Calvin cycle.[112] In the mid-nineties, 100-second 
oscillations of Ca2+ and cell membrane potential were found in heart myocytes under 
oxygen deprivation conditions.[113] Oscillations in the metabolic flux through the Krebs 

































































cycle throughout the mammalian cell cycle have recently been revealed using temporal 
fluxomics.[114] These and other examples are presented and explained as autocatalytic 
reactions exhibiting nonlinear dynamic behaviour similar to those of the Belousov-
Zhabotinsky chemical clocks in the classical Volkenstein's textbooks of Biophysics, as 
well as in the monumental The Geometry of Physical Time by Arthur Winfree.[115-117] 
The non-linear dynamics of these autocatalytic biochemical processes is connected with 
collective behaviours of auto-organization, as clearly exemplified by the auto-organized 
patterns of growth of the slime mold Dictyostelium discoideum in response to a wave of 
cAMP.[115-117] Based on this example, a tight connection could be suspected between 
metabolic oscillations and the deployment of patterns during morphogenesis, a research 
area that deserves to be revisited in the near future. These metabolic cycles can also 
have a role in fine tuning the synchronization of biological processes.[117,118] From the 
viewpoint of integrated regulation of metabolism, these metabolic oscillations are 
related to the general principle of metabolic regulation according to which organisms 
synchronously activate their catabolic processes and inhibit their biosynthetic processes 
under conditions of low chemical energy levels (for instance, due to nutritional 
deprivation). This is revealed by signals such as low ATP/AMP (or the equivalent 
energy charge) and NADH/NAD+ ratios, and via the AMPK signal transduction 
pathway.[9,119] The converse -an activation of biosynthetic pathways and an inhibition of 
catabolic pathways- occurs when the aforementioned ratios are high. An interesting 
redox oscillatory cycle has been characterized by the group led by the Morré marriage 
in a number of extracellular NADH oxidases (ENOX), including the tumour-associated 
ENOX isolated and characterized from the HeLa cell surface.[105,120,121] In a recent 
Editorial in this journal, Andrew Moore has suggested that metabolic cycles could play 
roles in cancer cells, an idea that deserves to be explored.[122]

































































6.3. Metabolic reprogramming occurs in immune cells and immune system 
responses
In the last few years, the evasion of the immune response has transpired to be the 
hallmark of cancer that is most likely to yield promising results as a therapeutic target in 
clinical oncology, as revealed by the Nobel Prize in Physiology or Medicine 2018 
awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by 
inhibition of negative immune regulation.[123] Its connections with (lymph)angiogenesis 
and metabolic reprogramming (other two hallmarks of cancer) in the context of cancer 
initiation, progression and metastasis has been studied, and is currently well 
documented.[73,123-128]  This has decisively contributed to a burst of interest in the 
connections between metabolic reprogramming and immune cells and immune system, 
giving rise to the growth of the new research area of immunometabolism. In this 
context, metabolic reprogramming of different types of immune cells (including B, NK, 
and T cells, as well as macrophages, among others) upon their activation and under 
different pathophysiological conditions (such as inflammation and exposure to 
pathogens) are also well documented.[129-146] The growth rate of immunometabolism 
research in the few last years is so high that metabolic reprogramming of immune cells 
has already become a hotspot similar to cancer metabolic reprogramming. 
6.4. Plants reprogram metabolism in response to heat, water, salt and other 
environmental stresses. 
Plants, along with fungi, are the eukaryotic organisms with the most complete and 
complex metabolic networks, possessing numerous pathways of secondary metabolism. 
Being rooted in the soil, plants cannot move or migrate in search of nutritional resources 

































































or in response to changes in environmental conditions. Therefore, plants are exceptional 
models for studying the extremely high level of sophistication of metabolic responses 
that continuously fine-tune the biological conditions of the organism to these 
environmental conditions. Metabolic responses of plants to pathogens and to different 
kinds of abiotic stress are so well documented as to be included in the routine content of 
standard plant biochemistry textbooks.[100] It is well known that plant acclimation to 
heat stress involves the synthesis of several heat shock proteins with major functions in 
the control of protein activity, leading to many changes in cellular metabolism, albeit a 
great part of them are still poorly understood.[100,147,148] In the current scenario of 
climate change, the responses of plants to heat stress are particularly relevant.[149-152] 
However, metabolic responses to a number of other abiotic stresses, including flood, 
drought, salt, and cold stress, among others, have been reported.[153-156]  
6.5. Other relevant metabolic reprogramming responses
Transitions between rest and exercise. The metabolic adaptations in the transitions 
rest/exercise, the differences of the metabolic modifications linked to training for 
strength exercise and endurance exercise and the different metabolic impacts of acute 
and chronic exercise are well documented.[8,9,157,158] 
Hibernation. It is well known that hibernating animals depress their general 
metabolic functions. AMP kinase has an essential role in this metabolic depression.[159] 
Aging. Aging is accompanied by a number of changes in metabolism. Some of these 
changes give rise to sarcopenia, a progressive loss of skeletal muscle strength and mass. 
It has been shown that the use of the metabolic modulator trimetazidine induces 
myogenesis though a metabolic reprogramming that stimulates differentation of skeletal 

































































muscle progenitors and increases the levels and activity of proteins involved in the 
oxidative metabolism of aged myocytes.[160]
Integrated metabolic changes in different parts and organs of a pluricellular 
individual living being. Even in the same organism its different parts and organs 
respond autonomously but in concert with changes in bioenergetic and biosynthetic 
demands, as excellently illustrated by the spectacular variety of metabolic flow modes 
in which enzymes from the Krebs cycle may be involved in different plant tissues under 
different lighting conditions, nutritional stress, etc.[161] 
7. Conclusions and Outlook
The notion of metabolic reprogramming as one of the hallmarks of cancer has had a 
big impact on basic, translational and clinical oncology research, giving rise to the 
concept of an "oncometabolite" and to the FDA approval of the first drugs targeting 
metabolism for the treatment of several types of cancer.[162-166] The characteristically 
elevated glucose uptake by many cancers is the foundation of the use of positron 
emission tomography (PET) for cancer diagnostic and treatment follow-up based in the 
use of the non-metabolizable glucose analogue 2-[18F]-fluoro-2-deoxy-D-glucose.[167] In 
oncology, processes involving metabolic remodeling such as the so-called Crabtree and 
Chance effects remain to be "re-discovered".[168,169] And the metabolic connections 
between the tumor and its host deserve to be further investigated within the frame of the 
tumor macroenvironment concept.[170-172] The roles of cancer cell metabolic cycles in 
non-linear dynamics of autoorganization in tumors should be further explored.[115-
117,120,122] Furthermore, the notion of metabolic reprogramming has pervaded the whole 
biomedical research arena, finding applications in the description of metabolic changes 
found between different diseases and the healthy state. Metabolic reprogramming has 

































































been identified as occurring in alcoholic liver disease, aplastic anemia, inflammatory 
diseases, ischemic heart failure, ischemic-reperfusion injury, amyotrophic lateral 
sclerosis, bacterial infections, Zika virus infection, and lung disease, among many 
others.[74, 173-183]
The main conclusion derived from this article is that metabolic reprogramming is not 
only a hallmark of cancer or other diseases, but rather the main hallmark of metabolism 
itself: it is the consequence of the extraordinary capacity of the dynamic metabolic 
networks to readjust themselves by rewiring to reach optimal adaptation to each great or 
small change in the cell-external and -internal environments.  Doubtless, a better 
understanding of metabolism and its remodelling potential will contribute to finding 
solutions to current challenges in biomedicine and beyond. 
Under the present global climate change scenario, heat stress can have terrifying 
effects on world crop production. A better understanding on how plants reprogram their 
chloroplast metabolism under heat stress could contribute to finding new ways to 
counter the impact of global climate change on crop production.[153] Other 
environmental challenges could also be solved with the help of a better understanding of 
the metabolic adjustments (that is, the metabolic reprogramming) associated with them.
The potential and power of the metabolism as a genuine engine of life never ceases 
to surprise and amaze us. My view is that, indeed, metabolism cannot be considered 
metaphorically "just" the engine of life, rather it is also the complex and dynamic set of 
interconnected biomolecular machines including sensors that detect both internal and 
external changes (in terms of matter, energy or information), and central processing 
units, able to process inputs and to generate biological response, always connected to a 
continuous fine tuning of the engine of life (Figure 4). The current renewed interest in 

































































metabolism should contribute to its re-positioning at the core of life. And not only at the 
core of each individual living being, but at the core of life as an emergent, collective 
phenomenon of the biosphere. Metabolism is intrinsically connected to life at all the 
scales. Nutrient cycles in the biosphere and the geophysiology inherent in the Gaia 
theory can be considered higher scale manifestations of metabolism.[184-186] I am sure 
that in the immediate future many new surprises await us in this exciting subject. 
Repositioning metabolism at the core of life will undoubtedly contribute to a better 
understanding of biological processes and life itself. Metabolism is the main hallmark of 
life.
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BOX 1: The metabolism is the engine of life.
In the last third of the 20th century, the Chilean neurobiologist Humberto Maturana 
introduced the concept of autopoiesis to refer to the inherent properties of life, a concept 
he developed extensively and lucidly in the book "The Tree of Knowledge",[187] co-
authored by his disciple Francisco Varela. Here they point out that "living beings are 
characterized because, literally, they continuously produce themselves, which we 
indicate when we call the organization that defines them autopoietic organization [...] 
In the first place, the molecular components of a cellular autopoietic unit must be 
dynamically related in a continuous network of interactions". That dynamic network is 
the metabolism and its capacity to change by adapting to external and internal changes 
is what we call metabolic reprogramming. According with this and with the 
thermodynamics understanding of metabolism introduced in section (2), metabolism is 
essential to dynamically display the biological information contained in genes and to 
generate and maintain all the complex molecular machinery that performs the essential 
functions to keep us alive. In short, the metabolism is the real engine of life.


































































Figure 1. The metabolic network. A eukaryotic cell can produce about 30,000 
different proteins, many of them enzymes that catalyze thousands of metabolic reactions 
involving many hundreds of metabolites. The depicted network is the overview 
metabolism map (map01100) provided by KEGG PATHWAY database 
(http://www.genome.ad.jp/kegg/pathway/map/map01100.htm). Each point (node) of 
this map represents a metabolite and each line (edge) connecting two metabolites 
represents the biochemical reaction corresponding to the transformation of one of the 
metabolites in the other. It is important to note that this representation is a fixed image, 
while a main feature of the metabolic network is its capability to change in time in 
response to changes in both the internal and external environments.
Figure 2. Network science identifies three main kinds of networks: random 
networks, scale-free Networks (also known as small-world networks) and hierarchical 
networks. As in the example depicted, hierarchical networks use to exhibit a remarkable 
modularity. The metabolic network is hierarchical and modular, and this fact renders 
metabolism a particularly robust network.
Figure 3. Energy metabolism reprogramming in yeasts. Under aerobic conditions, 
the tricarboxylic acid (or Krebs) cycle works as depicted in the left figure. The image 
inside the cycle is Sir Hans Krebs' photo, distributed by the Nobel Foundation when he 
was awarded with the Nobel Prize in Physiology or Medicine in 1953. The reader's 
attention is drawn to the fact that when Krebs initially described the tricarboxylic acid 
cycle the enzyme citrate synthase was still unknown. Under anaerobic conditions, the 

































































enzyme alpha-ketoglutarate dehydrogenase becomes inactive and the Krebs cycle 
breaks and becomes a branched biosynthetic pathway, as initially demonstrated by the 
group led by Federico Mayor Zaragoza, a former UNESCO Director-General.[92]
Figure 4. A metaphor of metabolism as the complex, dynamic set of biomolecular 
machines comprising the sensors (A) able to detect changes in both external and internal 
signals (in terms of energy, matter or information), the CPUs (Central Processing Units) 
(B) able to process and integrate these signals producing messengers and biological 
responses continuously fine-tuning the engine (C) of life, yielding final biological 
responses always associated with dynamic metabolic changes. (Figure designed by 
María Medina Amores).
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